I agree with you that Afterpay is grossly overvalued but lack of sellers = price appreciation.
Very little short interest in APT
i disagree that Zip is a growth stock as evidenced by saturation in ANZ and the competition and margin squeeze it now faces in all territories
If you discount the growth element it's fundamental book value is 53 cents and even less on a fully diluted basis
Simply put it does not warrant a growth stock premium and currently trading at 17 times book value there is scope for significant downside from here IMO
.
- Forums
- ASX - By Stock
- Ann: Becoming a substantial holder
I agree with you that Afterpay is grossly overvalued but lack of...
Featured News
Add ZIP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.25 |
Change
-0.110(3.27%) |
Mkt cap ! $4.243B |
Open | High | Low | Value | Volume |
$3.34 | $3.35 | $3.23 | $32.31M | 9.883M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 20480 | $3.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.26 | 50584 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 20480 | 3.250 |
27 | 335058 | 3.240 |
17 | 168219 | 3.230 |
22 | 284335 | 3.220 |
19 | 164650 | 3.210 |
Price($) | Vol. | No. |
---|---|---|
3.260 | 50584 | 3 |
3.270 | 48777 | 6 |
3.280 | 74527 | 7 |
3.290 | 295220 | 8 |
3.300 | 258991 | 15 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
ZIP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online